We recently demonstrated that combined CADM1 and MAL promoter methylation analysis on physician-taken cervical scrapings of hrHPV-positive women was at least equally discriminatory for high-grade CIN as cytology or cytology combined with HPV16/18 genotyping[14]. The gene discussed is MAL; the disease is cervical squamous intraepithelial neoplasia.